Profile data is unavailable for this security.
About the company
Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).
- Revenue in EUR (TTM)2.41bn
- Net income in EUR115.62m
- Incorporated--
- Employees15.07k
- LocationAmplifon SpAVia Ripamonti 133MILANO 20141ItalyITA
- Phone+39 2574721
- Fax+39 257300033
- Websitehttps://www.amplifon.com/
More ▼
Mergers & acquisitions
| Acquired company | AMP:MIL since announced | Transaction value |
|---|---|---|
| SISH Tucson LLC | -15.88% | -- |
| Miracle-Ear Inc | -15.88% | -- |
Data delayed at least 15 minutes, as of Feb 10 2026 16:35 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AddLife AB | 982.31m | 52.68m | 1.64bn | 2.30k | 32.14 | 3.31 | 12.70 | 1.67 | 4.60 | 4.60 | 85.69 | 44.66 | 0.8105 | 3.83 | 5.87 | 4,549,891.00 | 4.36 | 3.82 | 6.05 | 5.80 | 38.09 | 37.80 | 5.38 | 4.66 | 0.6257 | 3.68 | 0.4671 | 31.71 | 1.52 | 14.64 | 122.22 | 1.58 | 22.47 | 0.00 |
| Embla Medical hf | 779.35m | 69.94m | 1.78bn | 4.19k | 25.21 | 2.36 | 14.68 | 2.28 | 1.22 | 1.22 | 13.62 | 13.05 | 0.5681 | 2.27 | 6.96 | 1,389,003.00 | 5.12 | 4.60 | 6.10 | 5.43 | 62.30 | 62.25 | 9.01 | 7.99 | 0.9445 | 7.22 | 0.3768 | 0.00 | 8.63 | 8.09 | 22.05 | 68.07 | 6.12 | -- |
| Elekta AB (publ) | 1.65bn | 27.47m | 1.91bn | 4.48k | 72.13 | 2.49 | 12.88 | 1.16 | 0.7646 | 0.7646 | 45.97 | 22.11 | 0.5781 | 3.35 | 3.09 | 3,872,796.00 | 0.9511 | 3.48 | 1.70 | 6.21 | 38.17 | 38.22 | 1.65 | 6.02 | 0.7918 | 7.51 | 0.4724 | 92.20 | -0.5685 | 4.29 | -81.80 | -26.22 | 15.56 | 5.92 |
| SCHOTT Pharma AG & Co KgaA | 986.21m | 146.45m | 2.12bn | 4.81k | 14.56 | 2.39 | 9.12 | 2.14 | 0.9724 | 0.9724 | 6.55 | 5.92 | 0.6496 | 4.07 | 3.89 | 204,990.60 | 9.68 | 11.86 | 13.71 | 16.87 | 33.71 | 34.65 | 14.90 | 15.68 | 1.12 | -- | 0.0874 | 10.95 | 3.04 | 11.04 | -2.16 | 13.58 | 11.15 | -- |
| Carl Zeiss Meditec AG | 2.23bn | 141.22m | 2.48bn | 5.78k | 17.28 | 1.15 | -- | 1.11 | 1.61 | 1.61 | 25.45 | 24.18 | 0.6555 | 2.04 | 4.65 | 385,147.30 | 4.19 | 8.00 | 5.03 | 9.78 | 52.76 | 56.02 | 6.39 | 11.56 | 1.44 | 7.57 | 0.2165 | 33.14 | 7.82 | 10.78 | -20.99 | 2.90 | 11.23 | 1.92 |
| Ambu A/S | 814.45m | 72.81m | 2.72bn | 5.43k | 42.24 | 3.81 | 21.98 | 3.33 | 2.04 | 2.04 | 22.85 | 22.64 | 0.8135 | 1.95 | 7.18 | 1,130,201.00 | 7.27 | 4.06 | 8.49 | 4.82 | 60.07 | 59.33 | 8.94 | 5.48 | 1.67 | 20.74 | 0.0845 | 21.23 | 11.98 | 11.10 | 159.15 | 20.37 | -2.24 | 7.17 |
| Asker Healthcare Group AB | 1.54bn | 44.12m | 2.88bn | 4.51k | 41.76 | -- | 24.95 | 1.87 | 1.92 | 1.92 | 54.47 | -- | 1.15 | 5.10 | 9.34 | 5,010,379.00 | 3.37 | -- | 4.36 | -- | 40.43 | -- | 2.94 | -- | 0.9924 | 3.40 | 0.4561 | -- | 11.69 | -- | 77.34 | -- | -- | -- |
| Amplifon SpA | 2.41bn | 115.62m | 3.16bn | 15.07k | 27.14 | 3.17 | 7.33 | 1.31 | 0.5144 | 0.5144 | 10.76 | 4.41 | 0.6234 | 20.42 | 10.46 | 159,803.00 | 3.00 | 4.21 | 4.36 | 5.78 | 22.49 | 61.07 | 4.81 | 7.16 | 0.5413 | 3.86 | 0.6612 | 41.46 | 6.60 | 6.82 | -6.29 | 5.99 | 9.95 | -- |
| Medacta Group SA | 645.73m | 94.88m | 3.38bn | 2.04k | 35.55 | 7.94 | 20.55 | 5.24 | 4.34 | 4.34 | 29.53 | 19.42 | 0.8113 | 0.853 | 5.83 | 309,116.60 | 11.92 | 9.07 | 15.29 | 11.84 | 67.55 | 69.31 | 14.69 | 11.57 | 0.9472 | 10.51 | 0.3751 | 18.68 | 15.62 | 13.71 | 53.89 | 43.79 | 15.22 | -- |
| Sectra AB | 210.47m | 60.81m | 3.43bn | 1.32k | 59.75 | 21.60 | 47.99 | 16.32 | 3.36 | 3.36 | 11.62 | 9.29 | 0.6688 | -- | 3.93 | 1,726,353.00 | 19.32 | 15.75 | 35.74 | 29.92 | 54.43 | 60.29 | 28.89 | 22.41 | -- | -- | 0.0505 | 19.27 | 19.85 | 4.47 | 31.51 | 18.87 | 7.19 | -- |
| Ottobock SE & Co KgaA | 1.64bn | 57.90m | 3.81bn | -- | 66.37 | 16.79 | 20.01 | 2.32 | 0.9048 | 0.9048 | 25.67 | 3.58 | -- | -- | -- | -- | -- | -- | -- | -- | 52.42 | -- | 3.42 | -- | 0.6458 | 3.18 | 0.8358 | -- | 7.33 | -- | -38.37 | -- | -- | -- |
| DiaSorin SpA | -100.00bn | -100.00bn | 4.17bn | 3.28k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.62 | -- | 9.57 | -- | 66.24 | -- | 19.69 | -- | -- | -- | 25.25 | 3.24 | 10.91 | 17.68 | 1.37 | 16.50 | 4.78 |
| Ypsomed Holding AG | 862.70m | 212.51m | 4.46bn | 2.00k | 20.97 | 5.04 | 14.88 | 5.16 | 14.21 | 14.21 | 57.70 | 59.14 | 0.6591 | 6.14 | 5.78 | 297,862.70 | 16.24 | 5.55 | 23.88 | 8.67 | 41.25 | 32.32 | 24.63 | 9.24 | 1.19 | 27.75 | 0.1199 | 19.78 | 36.54 | 13.69 | 11.66 | 49.46 | 18.48 | 61.54 |
Data as of Feb 10 2026. Currency figures normalised to Amplifon SpA's reporting currency: Euro EUR
11.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 4.57m | 2.02% |
| Comgest SAas of 31 Oct 2025 | 3.91m | 1.73% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 2.82m | 1.24% |
| T. Rowe Price Hong Kong Ltd.as of 30 Sep 2025 | 2.58m | 1.14% |
| Harris Associates LPas of 31 Dec 2025 | 2.52m | 1.12% |
| Cr�dit Mutuel Asset Management SAas of 31 Dec 2024 | 2.42m | 1.07% |
| Arca Fondi SGR SpAas of 30 Dec 2025 | 2.21m | 0.98% |
| Eaton Vance Advisers International Ltd.as of 31 Dec 2025 | 1.96m | 0.86% |
| BlackRock Fund Advisorsas of 08 Jan 2026 | 1.83m | 0.81% |
| Mirova SA (Investment Management)as of 31 Oct 2025 | 1.81m | 0.80% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
